PPARgamma and the thiazolidinediones: molecular basis for a treatment of 'Syndrome X'?

Abstract

Diabetes, Obesity and MetabolismVolume 4, Issue 4 p. 239-248 PPARγ and the thiazolidinediones: molecular basis for a treatment of ‘Syndrome X’? C. Sewter, C. Sewter University of Cambridge, Departments of Clinical Biochemistry and Medicine, Addenbrooke's Hospital, Cambridge, UK.Search for more papers by this authorA. Vidal-Puig, Corresponding Author A. Vidal-Puig University of Cambridge, Departments of Clinical Biochemistry and Medicine, Addenbrooke's Hospital, Cambridge, UK. A. Vidal-Puig, University of Cambridge, Departments of Clinical Biochemistry and Medicine, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QR, UK. E-mail:[email protected]Search for more papers by this author C. Sewter, C. Sewter University of Cambridge, Departments of Clinical Biochemistry and Medicine, Addenbrooke's Hospital, Cambridge, UK.Search for more papers by this authorA. Vidal-Puig, Corresponding Author A. Vidal-Puig University of Cambridge, Departments of Clinical Biochemistry and Medicine, Addenbrooke's Hospital, Cambridge, UK. A. Vidal-Puig, University of Cambridge, Departments of Clinical Biochemistry and Medicine, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QR, UK. E-mail:[email protected]Search for more papers by this author First published: 03 July 2002 https://doi.org/10.1046/j.1463-1326.2002.00187.xCitations: 17Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume4, Issue4July 2002Pages 239-248 RelatedInformation